Effectiveness, safety, and cost-effectiveness of fixed-dose combination of montelukast–bilastine versus montelukast–levocetirizine in allergic rhinitis: A prospective, randomized, open-label, parallel-group study
Montelukast/bilastine and montelukast/levocetirizine are effective in managing AR. However, montelukast/bilastine offers a better safety profile and is more cost-effective, making it a viable option for AR treatment.
Authors
- Chaitali Chindhalore
- Vijay Bidkar (ORCID: https://orcid.org/0000-0002-5868-907X)
- Mohit Kumar (ORCID: https://orcid.org/0000-0003-3322-4476)
- Ganesh Natthuji Dakhale
Institutions
- All India Institute of Medical Sciences, Nagpur (IN)
Publication Details
- Journal
- Perspectives in Clinical Research
- Published
- 2025-05-31
- DOI
- https://doi.org/10.4103/picr.picr_206_24
- Citations
- 1
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 1.62